Onyx Pharmaceuticals

About:

Onyx Pharmaceuticals is a biopharmaceutical company committed to improving the lives of people with cancer.

Website: http://www.onyx-pharm.com

Twitter/X: onyxpharm

Top Investors: Sequoia Capital, OrbiMed, Federated Kaufmann Fund, Domain Associates, Perceptive Life Sciences

Description:

Onyx Pharmaceuticals is a biopharmaceutical company committed to improving the lives of people with cancer. Their lead product is Nexavar (sorafenib), a novel, oral multiple kinase inhibitor that targets proteins involved in both tumor cell proliferation and angiogenesis.

Total Funding Amount:

$20M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

1992-01-01

Founders:

Frank McCormick, Kevin Kinsella, Larry Bock

Number of Employees:

101-250

Last Funding Date:

2002-05-09

IPO Status:

Public

Industries:

© 2025 bioDAO.ai